COVID Funding
RBHS COVID-19 Clinical Trials
RBHS is actively engaged in scientific discovery surrounding COVID-19.
Below are RBHS COVID-19 clinical trials.
RBHS Active COVID-19 Clinical Trials
| Study Title | PI |
| A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 | Yonatan Greenstein |
| A randomized controlled trial to evaluate the outcomes with Aggrenox in patients with SARS-CoV-2 infection | Amit Singla |
| A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older | Shobha Swaminathan |
| C298-020; A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safetyand Efficacy of DUR-928 in Subjects Infected with SARS-CoV-2 with Acute or Chronic Liver or Kidney Disease | Nikolaos Pyrsopoulos |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Ruxolitinib in Participants With COVID-19–Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) | Amee Patrawalla |
| A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection | Rey Panettieri Keith Guevarra |
| Treatment of Patients Hospitalized for Covid-19 Infection and Pulmonary Distress with Zanubrutinib | Tilly Varughese |
| A5395 A Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons with COVID-19 | Michelle Dalla Piazza |
| Investigational Covid-19 Convalescent Plasma Infusion for severely or life-threateningly ill Covid-19 Patients | Marc Klapholz |
| Emergency Use of COVID-19 Covalescent Plasma in a Patient with Coronavirus Disease (COVID-19) | Marc Klapholz Tilly Varughese |
| A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection | Rey Panettieri |
| Clinical Features of COVID-19 Disease in Critically Ill Patients in the US: A Multicenter Study | Jared Radbel |
| Hemolung RAS Emergency Use Authorizations for COVID-19 | Sabiha Hussain Jared Radbel |
| A Randomized, Double-blind, Vehicle-Controlled, Multicenter, Parallel-Group Study of APL-9 in Mild to Moderate Acute Respiratory Distress Syndrome Due to COVID-19 | Sabiha Hussain |
| A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older | Jeffrey Carson |
| Influenza and Other Emerging Respiratory Pathogens Surveillance Registry | Lawrence Kleinman |
| Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Severe Influenza-Associated Illness and Understanding Coronavirus Disease 2019 (Overcoming COVID-19) in US Children | Lawrence Kleinman |
| The Pediatric COVID-19 Experience in Central New Jersey | Lawrence Kleinman |
| Seroprevalence of infection with SARS-CoV-2 Virus | Marila Gennaro |
| Fecal Study on COVID-19 Patients | Vinod Rustgi |